|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2000-2-7
|
|
pubmed:abstractText |
To examine the long-term clinical course and prognostic factors of patients with advanced aggressive non-Hodgkin's lymphoma (NHL) treated with third-generation regimens as front-line chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0390-6078
|
|
pubmed:author |
pubmed-author:Anticoli BorzaPP,
pubmed-author:BendandiMM,
pubmed-author:BocchiaMM,
pubmed-author:CelliniCC,
pubmed-author:De RenzoAA,
pubmed-author:GherlinzoniFF,
pubmed-author:GobbiMM,
pubmed-author:LautaV MVM,
pubmed-author:MagagnoliMM,
pubmed-author:MandelliFF,
pubmed-author:MartelliMM,
pubmed-author:PalombiFF,
pubmed-author:PavoniAA,
pubmed-author:RonconiFF,
pubmed-author:ScaramucciLL,
pubmed-author:StefoniVV,
pubmed-author:StortiSS,
pubmed-author:TuraSS,
pubmed-author:ZaimSS,
pubmed-author:ZinzaniP LPL
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
84
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
996-1001
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:10553159-Adolescent,
pubmed-meshheading:10553159-Adult,
pubmed-meshheading:10553159-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10553159-Bleomycin,
pubmed-meshheading:10553159-Cyclophosphamide,
pubmed-meshheading:10553159-Cytarabine,
pubmed-meshheading:10553159-Disease-Free Survival,
pubmed-meshheading:10553159-Doxorubicin,
pubmed-meshheading:10553159-Female,
pubmed-meshheading:10553159-Fluorouracil,
pubmed-meshheading:10553159-Humans,
pubmed-meshheading:10553159-Leucovorin,
pubmed-meshheading:10553159-Lymphoma, Non-Hodgkin,
pubmed-meshheading:10553159-Male,
pubmed-meshheading:10553159-Methotrexate,
pubmed-meshheading:10553159-Middle Aged,
pubmed-meshheading:10553159-Prednisone,
pubmed-meshheading:10553159-Retrospective Studies,
pubmed-meshheading:10553159-Salvage Therapy,
pubmed-meshheading:10553159-Treatment Outcome,
pubmed-meshheading:10553159-Vincristine
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?
|
|
pubmed:affiliation |
Istituto di Ematologia e Oncologia Medica "Seràgnoli", Policlinico S.Orsola, via Massarenti 9, 40138 Bologna, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|
